Patents by Inventor Andrew J. Easton

Andrew J. Easton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ASSAY AND MEDICAMENT
    Publication number: 20220325251
    Abstract: The disclosure relates to defective interfering viruses and defective interfering virus RNAs that are effective as antiviral agents. The disclosure also relates to methods for identifying defective interfering virus RNAs that can be used as effective antiviral agents.
    Type: Application
    Filed: April 21, 2022
    Publication date: October 13, 2022
    Inventors: Nigel J. DIMMOCK, Andrew J. EASTON
  • Assay and medicament
    Patent number: 11339374
    Abstract: The invention relates to defective interfering viruses and defective interfering virus RNAs that are effective as antiviral agents. The invention also relates to methods for identifying defective interfering virus RNAs that can be used as effective antiviral agents.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: May 24, 2022
    Assignee: The University of Warwick
    Inventors: Nigel J. Dimmock, Andrew J. Easton
  • ASSAY AND MEDICAMENT
    Publication number: 20200231939
    Abstract: The invention relates to defective interfering viruses and defective interfering virus RNAs that are effective as antiviral agents. The invention also relates to methods for identifying defective interfering virus RNAs that can be used as effective antiviral agents.
    Type: Application
    Filed: December 21, 2018
    Publication date: July 23, 2020
    Inventors: Nigel J. Dimmock, Andrew J. Easton
  • ASSAY AND MEDICAMENT
    Publication number: 20160333321
    Abstract: The invention relates to defective interfering viruses and defective interfering virus RNAs that are effective as antiviral agents. The invention also relates to methods for identifying defective interfering virus RNAs that can be used as effective antiviral agents.
    Type: Application
    Filed: January 16, 2015
    Publication date: November 17, 2016
    Inventors: Nigel J. Dimmock, Andrew J. Easton